Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.
Khouri, I F
Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL. [electronic resource] - Bone marrow transplantation Jan 2017 - 28-33 p. digital
Publication Type: Comparative Study; Journal Article
1476-5365
10.1038/bmt.2016.204 doi
Adult
Aged
Bendamustine Hydrochloride--administration & dosage
Cyclophosphamide--administration & dosage
Disease-Free Survival
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--mortality
Male
Middle Aged
Rituximab--administration & dosage
Survival Rate
Transplantation Conditioning--methods
Vidarabine--administration & dosage
Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL. [electronic resource] - Bone marrow transplantation Jan 2017 - 28-33 p. digital
Publication Type: Comparative Study; Journal Article
1476-5365
10.1038/bmt.2016.204 doi
Adult
Aged
Bendamustine Hydrochloride--administration & dosage
Cyclophosphamide--administration & dosage
Disease-Free Survival
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--mortality
Male
Middle Aged
Rituximab--administration & dosage
Survival Rate
Transplantation Conditioning--methods
Vidarabine--administration & dosage